The relationship of homocysteine and its redox forms with renal toxicity after high-dose methotrexate treatment in patients with leukemia or lymphoma.
Monitoring specific blood markers during chemotherapy could help identify which children face higher kidney damage risk early.
High-dose methotrexate (HD-MTX) chemotherapy inhibits dihydrofolate reductase, leading to impaired homocysteine metabolism, elevated levels, and associated clinical adverse reactions. In pediatric patients, Hcy/HHcy was significantly negatively correlated with creatinine (CR) (P < 0.
What the study was
- Study design
- Observational study
- Population
- Adult patients (see abstract)
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Frontiers in pharmacology
Why it surfaced
Design: Observational study; Topics: Hematologic malignancies; Species: human. Score=6/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.